These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 37489740)

  • 1. State of Shock: Contemporary Vasopressor and Inotrope Use in Cardiogenic Shock.
    Bloom JE; Chan W; Kaye DM; Stub D
    J Am Heart Assoc; 2023 Aug; 12(15):e029787. PubMed ID: 37489740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inotropes and vasopressors use in cardiogenic shock: when, which and how much?
    Levy B; Buzon J; Kimmoun A
    Curr Opin Crit Care; 2019 Aug; 25(4):384-390. PubMed ID: 31166204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasopressor and Inotrope Therapy in Cardiac Critical Care.
    Jentzer JC; Hollenberg SM
    J Intensive Care Med; 2021 Aug; 36(8):843-856. PubMed ID: 32281470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologic therapies for acute cardiogenic shock.
    Nativi-Nicolau J; Selzman CH; Fang JC; Stehlik J
    Curr Opin Cardiol; 2014 May; 29(3):250-7. PubMed ID: 24686400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inotropic Agents and Vasopressors in the Treatment of Cardiogenic Shock.
    Shabana A; Dholoo F; Banerjee P
    Curr Heart Fail Rep; 2020 Dec; 17(6):438-448. PubMed ID: 33103204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current real-life use of vasopressors and inotropes in cardiogenic shock - adrenaline use is associated with excess organ injury and mortality.
    Tarvasmäki T; Lassus J; Varpula M; Sionis A; Sund R; Køber L; Spinar J; Parissis J; Banaszewski M; Silva Cardoso J; Carubelli V; Di Somma S; Mebazaa A; Harjola VP;
    Crit Care; 2016 Jul; 20(1):208. PubMed ID: 27374027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiogenic shock: Inotropes and vasopressors.
    Amado J; Gago P; Santos W; Mimoso J; de Jesus I
    Rev Port Cardiol; 2016 Dec; 35(12):681-695. PubMed ID: 27836218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current evidence in the diagnosis and management of cardiogenic shock complicating acute coronary syndrome.
    Kaddoura R; Elbdri S
    Rev Cardiovasc Med; 2021 Sep; 22(3):691-715. PubMed ID: 34565070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cardiogenic shock: from pharmacological treatment to mechanical circulatory support].
    Battistoni I; Marini M; Lavorgna A; Vagnarelli F; Lucà F; Biscottini E; Caretta G; Procaccini V; Riva L; Vianello G; Iacoviello M; De Maria R; Navazio A; Aspromonte N; Di Lenarda A; Gulizia MM; Valente S
    G Ital Cardiol (Rome); 2017 Oct; 18(10):708-718. PubMed ID: 29105685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of medical management of cardiogenic shock in the era of mechanical circulatory support.
    Blumer V; Marbach J; Veasey T; Kanwar M
    Curr Opin Cardiol; 2022 May; 37(3):250-260. PubMed ID: 35612937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative Effectiveness and Safety Between Milrinone or Dobutamine as Initial Inotrope Therapy in Cardiogenic Shock.
    Lewis TC; Aberle C; Altshuler D; Piper GL; Papadopoulos J
    J Cardiovasc Pharmacol Ther; 2019 Mar; 24(2):130-138. PubMed ID: 30175599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inotrope and vasopressor use in cardiogenic shock: what, when and why?
    Hu K; Mathew R
    Curr Opin Crit Care; 2022 Aug; 28(4):419-425. PubMed ID: 35792520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiogenic shock.
    Rackley CE; Russell RO; Mantle JA; Rogers WJ
    Cardiovasc Clin; 1981; 11(3):15-24. PubMed ID: 7214388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasopressors and Inotropes as Predictors of Mortality in Acute Severe Cardiogenic Shock Treated With the Impella Device.
    Rohm CL; Gadidov B; Ray HE; Mannino SF; Prasad R
    Cardiovasc Revasc Med; 2021 Oct; 31():71-75. PubMed ID: 33309042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The medical treatment of cardiogenic shock.
    García-Delgado M; Rodríguez-García R; Ochagavía A; Rodríguez-Esteban MLÁ
    Med Intensiva (Engl Ed); 2024 Aug; 48(8):477-486. PubMed ID: 38834498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early Mechanical Circulatory Support for Cardiogenic Shock.
    Upadhrasta S; Museedi A; Thannoun T; Chaanine AH; Le Jemtel TH
    Cardiol Rev; 2023 Jul-Aug 01; 31(4):215-218. PubMed ID: 36730923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inotropic agents in cardiogenic shock.
    Polyzogopoulou E; Arfaras-Melainis A; Bistola V; Parissis J
    Curr Opin Crit Care; 2020 Aug; 26(4):403-410. PubMed ID: 32496275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The medical treatment of cardiogenic shock: cardiovascular drugs.
    De Backer D; Arias Ortiz J; Levy B
    Curr Opin Crit Care; 2021 Aug; 27(4):426-432. PubMed ID: 33797431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of vasopressors and inotropics in cardiogenic shock].
    Lemm H; Dietz S; Janusch M; Buerke M
    Herz; 2017 Feb; 42(1):3-10. PubMed ID: 28101622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical therapy of cardiogenic shock: Contemporary use of inotropes and vasopressors.
    Riccardi M; Pagnesi M; Chioncel O; Mebazaa A; Cotter G; Gustafsson F; Tomasoni D; Latronico N; Adamo M; Metra M
    Eur J Heart Fail; 2024 Feb; 26(2):411-431. PubMed ID: 38391010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.